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Abstract 
Background: Recent studies indicate that exposure to environmental chemicals may increase susceptibility to devel-
oping metabolic diseases. This susceptibility may in part be caused by changes to the epigenetic landscape which 
consequently affect gene expression and lead to changes in lipid metabolism. The epigenetic modifier enhancer of 
zeste 2 (Ezh2) is a histone H3K27 methyltransferase implicated to play a role in lipid metabolism and adipogenesis. In 
this study, we used the zebrafish (Danio rerio) to investigate the role of Ezh2 on lipid metabolism and chromatin status 
following developmental exposure to the Ezh1/2 inhibitor PF-06726304 acetate. We used the environmental chemical 
tributyltin (TBT) as a positive control, as this chemical is known to act on lipid metabolism via EZH-mediated path-
ways in mammals.
Results: Zebrafish embryos (0–5 days post-fertilization, dpf ) exposed to non-toxic concentrations of PF-06726304 
acetate (5 μM) and TBT (1 nM) exhibited increased lipid accumulation. Changes in chromatin were analyzed by the 
assay for transposase-accessible chromatin sequencing (ATAC-seq) at 50% epiboly (5.5 hpf ). We observed 349 altered 
chromatin regions, predominantly located at H3K27me3 loci and mostly more open chromatin in the exposed sam-
ples. Genes associated to these loci were linked to metabolic pathways. In addition, a selection of genes involved in 
lipid homeostasis, adipogenesis and genes specifically targeted by PF-06726304 acetate via altered chromatin accessi-
bility were differentially expressed after TBT and PF-06726304 acetate exposure at 5 dpf, but not at 50% epiboly stage. 
One gene, cebpa, did not show a change in chromatin, but did show a change in gene expression at 5 dpf. Interest-
ingly, underlying H3K27me3 marks were significantly decreased at this locus at 50% epiboly.
Conclusions: Here, we show for the first time the applicability of ATAC-seq as a tool to investigate toxicological 
responses in zebrafish. Our analysis indicates that Ezh2 inhibition leads to a partial primed state of chromatin linked to 
metabolic pathways which results in gene expression changes later in development, leading to enhanced lipid accu-
mulation. Although ATAC-seq seems promising, our in-depth assessment of the cebpa locus indicates that we need to 
consider underlying epigenetic marks as well.
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Background
In the last decades, the incidence of metabolic diseases 
such as obesity, type 2 diabetes mellitus (T2DM) and 
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non-alcoholic fatty liver disease (NAFLD) has increased 
enormously in adults, but also alarming increases of 
these diseases have been observed among children 
and young adults [1, 2]. Next to changes in lifestyle and 
genetic predisposition, recent studies have shown that 
environmental factors may also play an important role 
in the development of metabolic diseases, possibly via 
altered (epi)genetic status [3]. Exposure during early life 
stages to metabolism disrupting chemicals (MDCs) has 
been identified as an environmental factor which may 
play a role in the development of metabolic diseases later 
in life. MDCs are a class of endocrine disrupting chemi-
cals that have the ability to promote metabolic changes 
that may lead to increased susceptibility to develop obe-
sity, T2DM or fatty livers in animals and humans [4, 5].
Experimental evidence indicates that developmental 
exposures to MDCs can induce changes to epigenetic 
programming leading to altered metabolism and latent 
onset of metabolic diseases [3, 6]. Epigenetics describes 
processes that affect how DNA is wrapped into chro-
matin and expressed without altering its sequence, ulti-
mately shaping a phenotype [7]. Several different types of 
epigenetic modifications are thought to play a role in reg-
ulating metabolism, including DNA methylation, histone 
post-translational modifications (PTMs), and non-coding 
RNA molecules, each influencing an open or a closed 
state of chromatin depending on the type and location 
of the modification [8]. As a consequence, a more open 
transcriptionally permissive (euchromatin) or a closed 
repressive chromatin (heterochromatin) structure leads 
to either more active or repressed genes [9]. Ablation of 
specific histone modifications can shift the homeostatic 
balance of PMTs resulting in a change in gene expression, 
and consequently leading to a distinct phenotype such as 
altered lipid metabolism.
One of the factors that could play an important role in 
this process is enhancer of zeste 2  (EZH2), the catalytic 
factor of the Polycomb Repressive Complex 2 (PRC2) 
that places a methylation mark on histone H3 lysine 27 
(H3K27me1, 2 or 3) through its methyltransferase activ-
ity [10]. For instance, in mice and rodent cell lines it has 
been shown that repression of Wnt genes through H3K27 
methylation by EZH2 in preadipocytes is required for 
in  vitro adipocyte differentiation [11]. In contrast, inhi-
bition of EZH2 showed enhanced lipid accumulation in 
breast cancer cell lines and in a hepatocyte (HepG2) cell 
line [12, 13].
Enhanced adipogenesis as an adverse effect of expo-
sure to MDCs is often accompanied by changes in epi-
genetic gene regulation as previously found [14–20]. 
For example, prenatal exposure to the MDC tribu-
tyltin (TBT) increases the number of adipocytes in 
mice offspring [21]. Additionally, prenatal exposure to 
TBT leads to a change in adipogenesis in the F4 gen-
eration, which is linked to changes in sperm chromatin 
structures. Of importance, activation of the retinoid 
X receptor (RXR) by TBT or a RXR-selective ago-
nist (IRX4204) showed a reduced expression of EZH2 
[20]. As a consequence, redistribution and an overall 
decrease of H3K27me3 were observed, especially close 
to genes involved in adipogenesis [20]. From the above 
it becomes evident that histone PTMs via EZH2 play 
a role in adipogenesis, but other PTMs or DNA meth-
ylation might play an equal important role in shaping 
the epigenetic landscape. Also, exposure to TBT in 
zebrafish leads to enhanced lipid accumulation [22] 
and adipogenesis in zebrafish embryos and larvae at 
low concentration [23]. Therefore, we hypothesize 
that TBT can act through Rxr and down-regulate the 
expression of ezh2. Next to that, we hypothesize that 
inhibition of Ezh2 protein in zebrafish lead to altered 
lipid accumulation as an effect of a more open chro-
matin status and an accompanied change in gene 
expression.
In this study, we use zebrafish (Danio rerio) as a model 
to investigate inhibition of Ezh2 on lipid metabolism. 
Transparent zebrafish embryos allow the visualiza-
tion of developmental phenotypes following exposure 
to chemicals. Also, many protein coding genes in the 
zebrafish genome are conserved, including ezh1 and ezh2 
and other Polycomb genes, showing high similarity with 
higher vertebrates as humans [24]. However, only Ezh2 
is required for zebrafish embryo development. Although 
the role of Ezh2 during early development is studied 
quite in depth, the role of Ezh2 in lipid metabolism in 
zebrafish is unknown. We investigated the effect of inhi-
bition of the histone methyl transferase (HMT) activity of 
enhancer of zeste proteins on zebrafish development with 
focus on lipid accumulation, and chromatin accessibility 
due to reduced H3K27me3 levels. Therefore, we exposed 
zebrafish embryos to the Ezh inhibitor PF-06726304 
acetate [25], and measured changes on chromatin struc-
ture by the assay for transposase-accessible chromatin 
sequencing (ATAC-seq), just after zygotic genome activa-
tion (ZGA) at 50% epiboly.
The zebrafish has become an important model in 
toxicology to study the effects of chemicals on early 
development and adults, and is used in transgenera-
tional studies as well. However, most research focus on 
phenotypic effects, often accompanied with changes in 
gene expression, but underlying epigenetic mechanisms 
are less prominently studied. In zebrafish, the chroma-
tin becomes remodeled during mid-blastula transition 
(MBT) and zygotic genome activation (ZGA) accompa-
nied with changes in histone methylation [26–28], how-
ever knowledge is lacking about the effect of exposures 
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to chemicals on histone modifications and chromatin sta-
tus. Most environmental epigenetic research has focused 
at DNA methylation or non-coding small RNA molecules 
[29], but emerging studies investigate the role of higher 
order chromatin structures via post-translational histone 
modifications [20, 30, 31] and chromatin structural anal-
yses [32]. Here, we investigated if chromatin accessibility 
can be used as an end-point in toxicological research as 
an indicator for change in gene expression directly after 
exposure and later in life.
In this study, we show that exposure to the Ezh2 inhibi-
tor, PF-06726304 acetate, has impact on lipid accumu-
lation in 5-dpf-old larvae. Importantly, we detected 
changes in chromatin status linked to H3K27me3 loci 
shortly after genome activation, which could be further 
linked to biological processes involved in metabolism. 
Furthermore, we characterized specific differentially reg-
ulated genes in order to gain knowledge on the specific 
mode of action of PF-06726304 acetate.
Results
Developmental exposure to PF‑06726304 acetate leads 
to moderate teratogenicity
To test whether inhibition of Ezh2 proteins may lead 
to a phenotypic effect on zebrafish embryonic devel-
opment, we exposed embryos from 0 to 5  days post-
fertilization to different concentrations of the Ezh2 
inhibitor PF-06726304 acetate (Fig.  1a; referred to as 
Ezh2i) (0.1 μM, 1 μM, 5 μM, 25 μM and 50 μM) and cor-
responding solvent controls (0.01, 0.05 an 0.1% DMSO) 
(Fig. 1b, c).
At 2 dpf, all the embryos within control and tested 
concentrations up to 25 μM Ezh2i had well-defined pig-
mented eyes, heartbeat and developed normally. The 
first signs of abnormalities such as heart sac edema, were 
observed in > 50% of embryos exposed to 50 μM of Ezh2i. 
All the embryos with heart edema had impaired blood 
circulation, as blood accumulation was visible under the 
yolk sac and around the heart. At 5 dpf, all embryos in 
controls and tested concentrations up to 25  μM were 
hatched and continued to grow, however, larvae exposed 
to 50 μM of Ezh2i showed a lethal effect to the compound 
in all replicates. At this concentration, all the uncoagu-
lated embryos failed to progress through development, 
some with clear body plan and eyes developed, but failed 
to hatch and died. A concentration–response curve of 
Ezh2i revealed an EC50 of 29 μM (Fig. 1c).
To further investigate the possible effects on general 
development and health of larvae, we measured the 
standard length (SL) of 5-dpf-old larvae. The average SL 
of larvae in control group was 3.7 mm. Overall, the aver-
age size of the larvae measured in each tested group lies 
between 3.6 and 3.8  mm. No significant difference in 
size was measured when comparing solvent control and 
tested concentrations of Ezh2i (Fig. 1d).
Exposure to Ezh inhibitor PF‑06726304 acetate augments 
lipid accumulation
From our concentration–response curve analysis, we 
chose a non-toxic concentration of 5 μM for all our sub-
sequent analyses. We performed a short (0 to 50% epiboly 
exposure, recovery up to 5 dpf; referred as Ezh2i50%epi 
samples) and long window exposure to Ezh2i (0–5 days 
exposure; Fig. 2a). A positive control (1 nM TBT) and a 
negative control (0.01% DMSO) were included in the set-
up (Fig.  2a). We performed neutral lipid dye Oil Red O 
(ORO) staining on paraformaldehyde fixed larvae, and 
these stained larvae showed presence of lipid staining in 
brain and abdominal area at different intensities at 5 dpf 
(Fig. 2b). To quantify the lipid staining, we measured the 
number of red pixels of the yolk sac area in control and 
exposed 5-dpf-old larvae using ImageJ. The experiment 
was performed in duplicate, and a two-way ANOVA 
analysis showed that there were no significant differences 
between the two independent experiments. Accumu-
lated data from the two experiments showed significantly 
increased lipid accumulation compared to solvent control 
in larvae exposed to the positive control TBT (1 nM), and 
the short and the long Ezh2i exposure (Fig. 2c). The mean 
value of solvent control group was 6071 pixels, compared 
to 7543 pixels for TBT, 7584 pixels Ezh2i50%epi and 8680 
pixels Ezh2i5dpf samples.
ATAC‑seq reveals altered chromatin accessibility 
at H3K27me3 loci
Sequences generated from the ATAC samples were 
of high quality with phred scores > 30 for all samples 
(Additional file 1: Fig. S1). The mapping to the GRCz11 
zebrafish genome resulted in around 40 million unique 
alignments on average per sample (Additional file  1: 
Fig.  S2). The alignments showed a typical ATAC pro-
file, identifying nucleosome positions around 200 and 
400  bp (Fig.  3a) [33]. In total 65336 peaks were identi-
fied using MACS2. Generally, the Log2 reads per mil-
lion values of the identified peaks showed a marginal 
increase towards the Ehz2 inhibitor (Fig.  3b). From the 
65,336 peaks, 22,026 were overlapping with genic regions 
(defined as 2000 bases ± mRNA region), and 19,331 
peaks were directly located at transcriptional start sites 
(TSS) (defined as 1000 bases ± TSS of mRNAs). A typi-
cal enrichment of ATAC peaks at TSSs and a decline of 
enrichment over gene bodies are shown in Fig. 3c, d with 
no apparent difference between exposures. From the 
peaks located at TSSs, 349 were identified as differen-
tially enriched (DE) between the Ezh2 inhibitor and con-
trols. When comparing the data with previous published 
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data on H3K4me3, H3K27ac, H3K4me1, H3K27me3, 
H3K36me3 and ATAC from dome stage embryos [34–
36], our data follow expected patterns resulting from 
Ezh2 inhibition. Enrichment plots of the 19331 ATAC 
peaks located at TSSs as shown in the upper panel of 
Fig. 3e show typical enrichments that are expected from 
ATAC data at H3K4me3/1, H3K27ac/me3 locations, but 
none at H3K36me3. A very sharp enrichment pattern is 
observed with previously published ATAC data, indicat-
ing that the locations of the peaks in this study are highly 
alike with the previous reported data. When focusing on 
the 349 DE peaks, a significant enrichment at H3K27me3 
locations is observed, indicating that indeed H3K27me3 
is targeted by the Ezh2i (Fig. 3e lower panel).
Differential ATAC peaks are linked to pancreatic cell 
development and metabolic pathways
From the 349 DE peaks, 302 were increased, representing 
more open chromatin, as is expected from H3K27me3 
inhibition (Fig.  4a). Correlation analysis showed a clear 
clustering of all exposed Ezh2i samples vs controls 
(Fig.  4b). Additionally, principal component analysis 
(PCA) revealed a separation between the controls and 
Fig. 1 Phenotypic effects of PF-06726304 acetate (Ezh2i). a Structural formula of PF-06726304 acetate (source: http://www.sigma aldri ch.com). b 
Developmental exposure to a concentration range of Ezh2i at 1, 2 and 5 days post-fertilization (dpf ). c Concentration–response curve of Ezh2i at 5 
dpf. d Length measurements of larvae following exposure to Ezh2i at 5 dpf. Error bars indicate standard deviation (SD)
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exposed samples. Principal component 1 (PC1) and PC2 
explained 44.6% and 17.2% of the total variance between 
the samples (Fig.  4c). Gene Ontology analysis showed 
most biological processes are enriched for processes 
linked to pancreatic alpha cell differentiation, hormone 
mediated signaling and response to lipids (Fig. 4d). Many 
metabolic processes were affected as is shown in the GO 
list per term in Additional file 2.
Differential ATAC peaks link to differential expressed genes 
from MZehz2 mutants
To test which chromatin regions are specifically targeted 
by the inhibitor, we compared a differentially expressed 
gene (DEG) list (padj < 0.05; 2904 genes) of MZehz2 
mutants with our DE peaks gene list [37]. MZezh2 
embryos do not possess the H3K27me3 mark on the 
genome and gene expression data should directly link to 
our ATAC data set. Using a Venn diagram we observed 
an overlap of 69 genes that were shared in both datasets 
(Fig. 5a), which is more than expected based on random 
sampling (P < 0.0001, Fisher exact test). Interestingly, 
gene ontology analysis of these 69 genes showed again an 
enrichment for pancreatic A cell differentiation (Fig. 5b), 
but also other processes in metabolism and lipid homeo-
stasis (Additional file 2).
Gene expression at 50% epiboly is not significantly 
changed
Embryos exposed to 5  μM Ezh2i or solvent control 
(0.1% DMSO) at 50% epiboly were analyzed for gene 
expression of a selection of genes from the overlapping 
ATAC-seq and RNA-seq gene list. In addition, we ana-
lyzed gene expression of adipogenic genes expressed as 
early as 50% epiboly. No effects of Ezh2 chemical inhi-
bition was found on expression of these genes at the 
50% epiboly stage (Fig. 5c).
Fig. 2 Lipid accumulation after exposure to PF-06726304 acetate (Ezh2i) and tributyltin (TBT). a Experimental design. Embryos are either exposed 
to Ezh2i or TBT in a short or long exposure window. b Representative images for ORO staining with low, medium or high staining levels. c Scatter 
plot of ORO staining following the different treatments. Average and error bars (95% CI) indicated in black (****padj-value < 0.0001)
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Long exposure to Ezh2i and TBT shows high similarity 
at gene expression level
Differences in gene expression between the different 
experimental groups were investigated using an over-
all comparison which is visualized in a heatmap by 
hierarchical clustering of experimental groups. Gene 
expression of TBT and Ezh2i5dpf samples show higher 
similarity compared to short exposure Ezh2i50%epiboly 
samples and solvent control group (Fig. 6a). Brain derived 
neurotrophic factor (bdnf), insulin growth factor bind-
ing protein 1a (igfbp1a) and ventral anterior homeobox 2 
Fig. 3 ATAC sequencing results of 50% epiboly embryos exposed to PF-06726304 acetate. a Read length distribution of sequences showing a 
typical ATAC fingerprint. b Violin plot showing log2 read per million (RPM) values of all ATAC peaks (dashed lines indicate median and quartiles). c 
Enrichment plot showing the global mapping of sequencing reads mapped around the transcriptional start sites (TSSs) of all genes. d Enrichment 
plot showing the global mapping of sequencing reads mapped over the relative length of all genes. e Density plots of different histone marks and 
accessible chromatin at dome stage around (upper part) all ATAC peaks and (lower part) differential enriched ATAC peaks located at TSSs spanning a 
region of 10 kb
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(vax2) that had increased DE peaks after ATAC-seq also 
showed higher fold change expression with qPCR. Bdnf 
was significantly higher expressed in samples exposed 
either short or longer to Ezh2i, while igfbp1a is signifi-
cantly higher expressed in TBT, Ezh2i5dpf samples and 
Ezh2i50%epiboly samples than solvent control samples. 
Vax2 was only significantly higher expressed in short 
exposure Ezh2i50%epiboly samples (Fig.  6b). Interest-
ingly, the retinoid X receptor alpha a (rxraa) is strongly 
down-regulated in the Ezh2i5dpf samples, without any 
change in enhancer of zeste 2 (ezh2) gene expression. 
CCAAT enhancer-binding protein alpha (cebpa) showed 
significant reduced expression in TBT and Ezh2i5dpf 
samples (Fig. 6c).
To further investigate the differences observed in gene 
expression after 5 days of exposure to Ezh2i, we related 
these changes back to the chromatin accessibility data. 
Both bdnf and igfbp1a showed a significant increase in 
enrichment at 50% epiboly (Fig. 7a, b). Although the gene 
expression did not change at 50% epiboly, the expres-
sion did increase at 5 dpf. On the other hand, at cebpa 
no changes were observed in chromatin accessibility 
(Fig.  7c), but a strong decrease in gene expression was 
observed at 5 dpf. To investigate this further we per-
formed ChIP-qPCR of H3K27me3 at different locations 
of the cebpa locus and found significant demethylation of 
underlying H3K27me3 at all locations around the gene, 
but not further upstream (Fig. 7d).
Discussion
Reprogramming of the epigenome is thought to be one 
of the mechanisms by which early developmental expo-
sure can influence disease susceptibility later in life, and 
possibly be transmitted to next generations [38]. Here, 
we show that developmental exposure to Ezh2i increases 
lipid accumulation in developed zebrafish larvae, linked 
to changes to the epigenome and gene expression. Our 
results also indicate a primed state of chromatin in early 
development leading to changes later in life, indeed fol-
lowing the hypothesis of the developmental origins of 
health and disease [38].
The aim of this study was to investigate the role of Ezh2 
inhibition on zebrafish embryo development and lipid 
accumulation in 5-dpf larvae, by using the newly devel-
oped Ezh inhibitor PF-06726304 acetate, targeting both 
Ezh1 and 2. However, this molecule will mainly inhibit 
the function of Ezh2 as Ezh1 is not expressed at detect-
able levels in zebrafish at early stages (up to 24 hpf), and 
remains low expressed until 6 dpf [39]. Furthermore, it 
has been shown that the PRC2–Ezh2 complex has higher 
HMT activity compared to the PRC2-Ezh1 complex [40].
Fig. 4 Differential enrichment (DE) analysis of ATAC peaks at transcriptional start sites (TSSs). a Scatterplot of peaks located at TSSs. Red dots 
indicate differentially enriched ATAC peaks. b Cluster analysis (Pearson correlation). c Principal component analysis of ATAC peaks located at TSSs 
(control in blue, exposed in red). d Top 10 gene ontology enrichment analysis (GO term biological process) of DE peaks at TSSs
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Embryos treated with different concentrations of 
Ezh2i showed normal early development. However, we 
observed cardiac edema in some of the embryos exposed 
to Ezh2i but only at the highest tested concentration 
(50  µM) at 2 dpf, and mortality with an EC50 value of 
29  µM at 5 dpf. Cardiac edema was also observed in 
embryos exposed to another Ezh inhibitor, DZNep [41], 
and myocardial defects are described in maternal zygotic 
mutant MZezh2hu5760/hu5760 embryos [42]. Zygotic ezh2 
mutants form a normal body plan, but die around 12 
dpf [16, 17]. MZezh2 embryos have normal gastrula-
tion, develop a normal body plan but die at 2 dpf showing 
pleiotropic phenotypes due to loss of tissue maintenance 
[37, 42]. Actually, these MZezh2 mutant embryos do 
not possess the H3K27me3 mark on the epigenome and 
gene expression analysis showed that genes important for 
Fig. 5 Gene expression at 50% epiboly is not significantly changed. a Venn diagram showed an overlap of 69 genes between DEP from ATAC 
sequencing and DEG after RNAseq on MZezh2 embryos. b Top 10 gene ontology enrichment analysis (GO term biological process) for 69 
overlapping genes between ATAC-seq and MZezh2 RNA-seq. c Gene expression at 50% epiboly shown with standard error of mean (SEM)
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Fig. 6 Gene expression analysis of genes involved in lipid processes or differential ATAC peaks. a Hierarchical clustering of gene expression. 
b Upregulated genes that also showed differential enhanced peaks (more reads). c Down-regulated genes after exposure to Ezh2i 
(***padj-value < 0.0001; ***padj-value < 0.001; **padj-value < 0.01; *padj-value < 0.05). Error bar indicate standard error of mean (SEM)
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early development are not switched off [37]. Although 
Ezh2 is essential for embryonic development and tis-
sue maintenance in zebrafish, maternal load of Ezh2 
mRNA is probably sufficient to add H3K27me3 mark 
to the chromatin in embryos as described previously 
in zygotic ezh2 mutants [37, 42]. Ezh2i will block the 
SET domain of specifically Ezh1/2 proteins and thereby 
inhibit the catalytic function to add the H3K27me3 
mark on the chromatin [43]. Indeed, when we map the 
ATAC DE peaks to H3K27me3 loci, we see a substantial 
over-representation at these locations. Reduced levels 
of H3K27me3 can lead to a more open chromatin status 
leading to higher expression of genes that normally are 
repressed. This can interfere with important biological 
processes during zebrafish development leading to non-
viable larvae as seen in the Ezh2 mutant experiments.
Fig. 7 Differential expressed genes versus ATAC results. Peak patterns around, a insulin growth factor binding protein 1a (igfbp1a), b brain 
derived neurotrophic factor (bdnf) and c CCAAT/enhancer-binding protein alpha (cebpa) (blue is control and red is exposed). d Chromatin 
immunoprecipitation qPCR at 5 locations around the cebpa locus with histone H3 lysine 4 trimethylation (H3K4me3) and histone H3 lysine 
27 trimethylation (H3K27me3) normalized against histone 3 (H3). Error bar reflects SEM. NoAb are no antibody controls. Black = control; 
grey = exposed. TSS: transcriptional start site
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By blocking the HMT activity of Ezh1/2 proteins by 
exposure to its inhibitor, we wanted to investigate the 
effect on lipid accumulation at a non-toxic concentration 
(5 µM). Lipid accumulation is enhanced both after short 
and longer exposure to Ezh2i as was shown by neutral 
lipid staining with Oil Red O, and at comparable levels as 
seen with positive control TBT. These findings corrobo-
rate with our earlier study with developmental exposure 
of TBT in zebrafish in which we observed a higher preva-
lence of larvae with adipocytes combined with higher 
amount of adipocytes in these larvae [23]. Additionally, 
other studies also found increased adiposity in either 
zebrafish larvae or juveniles [22, 44]. Enhanced adipo-
genesis may lead in turn to obesogenic phenotypes later 
in life, and related metabolic disorders [45]. Addition-
ally, similar effects of enhanced lipid accumulation have 
been observed in human cell lines. For instance, breast 
cancer cell lines treated with Ezh2 inhibitors, DNZep and 
GSK126, showed more lipid droplets [12]. Also HepG2 
cells treated with DNZep showed enhanced lipid accu-
mulation [13].
To get a better understanding of possible mechanisms 
involved in the increased lipid accumulation, we per-
formed ATAC sequencing just after ZGA, and observed 
349 DE peaks directly located at TSS. As a consequence 
of altered H3K27me3 levels on the chromatin, most DE 
peaks had more reads compared to controls reflecting 
a more open chromatin state. Gene Ontology analysis 
showed enrichment of genes involved in pancreatic A 
cell differentiation, (steroid) hormone mediated signal-
ing, important developmental genes, and neurological 
pathways. The variety in pathways and processes that 
have been altered is probably a result of the stochas-
tic effect of Ezh2 protein inhibition as normally PRC2–
Ezh2 complexes are recruited to multiple positions on 
the chromatin. Nevertheless, the over-representation of 
genes involved in metabolic processes could possibly be 
involved in the increased lipid accumulation observed in 
the embryos. Additionally, we compared our data with 
published gene expression data from MZezh2 mutants 
and searched for specifically targeted chromatin regions 
by the inhibitor. Although the published RNA-seq data 
was performed at the earlier dome stage, the moment 
that the zygotic genome becomes activated, a large over-
lap in genes was observed, which was accompanied by a 
large overlap in pathways, again linked to metabolism.
Interestingly, an assessment of gene expression of a 
selection of these genes did not reveal changes in gene 
expression at 50% epiboly directly after Ezh2i exposure. 
The concentration of Ezh2i (5 µM) used for genetic and 
phenotypic analysis is well below the EC50 level, which 
might explain the lack of changes in gene expression. 
However, we observed mostly more open chromatin 
which indicates a change in nucleosome positioning 
favoring recruitment of transcription factors and RNA 
polymerase II leading to altered, presumable higher, gene 
expression. As we performed ATAC seq at such an early 
developmental stage (50% epiboly), specific required 
transcription factors might not be recruited to those 
regions or are not available at this stage. In a sense the 
chromatin could be primed for gene expression changes 
later in development. Indeed, when we assessed whether 
these genes were affected at 5 dpf, of the positive ATAC 
genes, 3 genes (bdnf, igfbp1a and vax2) showed an 
increase in gene expression following the short exposure 
up to 50% epiboly and the recovery period to 5 dpf.
From our data, it remains unclear how Ezh2 is exactly 
involved in increased lipid accumulation. Gene expres-
sion profiles of TBT and the longer Ezh2i exposure 
showed a large overlap. Although only a relatively small 
set of genes were analyzed, these results might indi-
cate that TBT acts via a similar mechanism as shown in 
mammalian cell models. Activation of RXR by TBT or 
RXR agonists in committed preadipocytes resulted in 
lower expression of Ezh2 leading to overall lower levels 
of H3K27me3 and increased lipid accumulation [20]. If 
we extrapolate this to our findings in zebrafish, we see a 
decreased expression of rxraa following Ezh inhibition, 
which might be a negative feedback towards RXR, to pre-
vent further lipid accumulation. Still, detailed mechanis-
tic research is needed to address the exact mechanisms 
of action.
The question remains if we can use chromatin sta-
tus as an endpoint in toxicological research and if this 
can be linked to differentially expressed genes. We have 
shown that no change in the accessibility at the cebpa 
locus does not mean there is no change in H3K27me3 
or gene expression as cebpa showed a strong decrease 
in H3K27me3. This was reflected in lower gene expres-
sion levels at 5 dpf. The mechanisms behind this regu-
lation are currently unclear and are subject for further 
investigation, but it does show that ATAC-seq data in 
itself might not give a complete view on the epigenetic 
status. Conversely, a change in chromatin accessibility is 
not always linked to gene expression. Cross-talk between 
epigenetic marks such as DNA methylation and histone 
PTMs and recruitment of transcription factors will in the 
end determine the expression of a gene [46]. Therefore, 
we think that multiple endpoints for epigenetic modifi-
cations should be assessed before drawing any conclu-
sion about changes in epigenetic status. Nevertheless, 
the structural analysis of chromatin such as ATAC-seq 
seems a reasonable starting point for addressing changes 
at underlying epigenetic marks.
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Conclusions
Here, we show for the first time the applicability of ATAC 
sequencing in a toxicological setting in zebrafish follow-
ing Ezh2 inhibition. Ezh2i increased lipid accumulation 
in the same manner as the positive control TBT, and 
ATAC profiles revealed involvement in metabolic pro-
cesses and lipid metabolism. Gene expression profiles 
showed similar responses between TBT and Ezh2i. Our 
data further implies that Ezh2 inhibition in zebrafish 
might have a similar outcome for increased lipid accumu-
lation as in mammals, possibly via conserved pathways, 
but further research into this is needed. Although our 
data does show that underlying epigenetic marks might 
still be important to assess as well, ATAC sequencing 
holds promise for toxicological purposes in the future.
Methods
Zebrafish husbandry
At Utrecht University, wild-type zebrafish (AB) were 
maintained in tanks in a continuous flow system ZebTec 
(Techniplast). Tanks were filled with reverse osmosis 
water and 15% daily water exchange, kept at 28  °C and 
photoperiod of 10 h dark and 14 h light. Zebrafish were 
fed two times a day with Gemma Micron 300 (Skretting) 
and once with live brine shrimp. Male and female fish 
(1:1 ratio) were separated the night before mating and 
placed in the same tank with a divider separating them. 
The following morning, the divider was removed, and 
embryos were collected and transferred to petri dishes 
containing E3 embryo medium (5  mM NaCl, 0.17  mM 
KCl, 0.33  mM  CaCl2∙2H2O, 0.33  mM  MgSO4∙7H2O). 
At the day of exposure, fertilized eggs were selected 
for exposure experiment. Our experimental design did 
not need ethical committee approval as embryos used 
were beyond the stage defined as an animal experiment 
(≤ 5dpf). Our fish stocks are housed under license AVD 
1080020197366.
The Norwegian University of Life Sciences (NMBU) 
zebrafish facility is licensed by the Norwegian food 
inspection authority (NFIA) permit no. 5793. AB wild-
type zebrafish were maintained according to standard 
operating procedures with 28 °C and photoperiod of 10 h 
dark and 14 h light as described earlier [47].
Developmental exposure to PF‑06726304 acetate (Ezh2i)
PF-06726304 acetate (5,8-dichloro-2-[(1,2-dihydro-
4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-7-(3,5-dimethyl-
4-isoxazolyl)-3,4-dihydro-1(2H)-isoquinolinone acetate, 
CAS Number 1616287-82-1, 99% purity) was purchased 
from Sigma-Aldrich, and dissolved in dimethyl sulfoxide 
(DMSO, Sigma-Aldrich, D8418, purity > 99,9%) to obtain 
a stock concentration of 50  mM. Other dilutions were 
prepared from this stock (10  mM, 1  mM, 0.1  mM, and 
0.01 mM) in order to have a final DMSO concentration 
of 0.1 and 0.01% during exposure to zebrafish embryos. 
A 24-well plate was set up with control and test con-
centrations ranging between 0.01 and 50 μM, each with 
four replicates. On average, 10 embryos, all in the same 
developmental stage (4–8-cell stage), were placed in each 
well and incubated at 26  °C. Defects on development 
at 1 dpf, 2 dpf and 5 dpf were observed under a Motic 
stereo microscope (Motic SMZ-171T) and recorded on 
score sheets and percentage of mortality and percent-
age of effected embryos were calculated. Using GraphPad 
(V8) the EC50 and LC50 at 5 dpf was calculated. After 
screening, each well was photographed using the camera 
(Moticam 5, 5.0MP (2592 × 1944), CMOS sensor) of the 
stereomicroscope with (10× 2× 0.5×) 10 times magnifi-
cation using manufacturer’s software (Motic Images Plus 
3.0). Images were captured in TIFF format.
For lipid staining and qPCR analysis we used 6-well 
plates with each four replicates per chemical expo-
sure. Per well we exposed 50 embryos in 5  mL expo-
sure medium containing 0.01% DMSO (solvent control), 
positive control 1  nM TBT, short exposure to Ezh2i up 
to 50% epiboly which was refreshed with solvent control 
0.01% DMSO, and long exposure to Ezh2i up to 5 dpf. 
Two independent experiments were performed. Per well, 
10 embryos were fixated for lipid staining, and embryos 
were snap frozen in liquid nitrogen for qPCR analysis.
For omics analysis, embryos were collected directly 
after fertilization and kept at 28 ± 1  °C. Non-viable 
embryos were discarded from the exposures. Chemi-
cal exposure to the Ezh2i was performed in a 6-well 
plate, and each exposure was performed in triplicate. 
For ATAC-seq, 150 embryos were maintained in 9  mL 
of 5  μM PF-06726304 acetate and 150 embryos were 
maintained in 9  mL control solution (0.05% DMSO). 
The exposure time was from approximately 2-cell stage 
to 50% epiboly. For ChIP-qPCR, 200 embryos were 
maintained in 9  mL of 5  μM PF-06726304 acetate and 
200 embryos were kept in 9 ml solvent control solution 
(0.05% DMSO).
Oil Red O staining
For the whole mount Oil Red O (ORO) staining, 5-dpf-
old embryos were fixated in 4% paraformaldehyde over-
night at 4  °C. After a short wash with PBST (PBSzero 
with 0.05% Tween 20), three washes (3 × 10  min) with 
only PBSzero were performed. Next, we incubated the 
embryos in 60% isopropanol for 1 h, followed by a 0.3% 
ORO staining in 60% isopropanol for 75  min. After the 
staining, the embryos were immediately transferred 
in PBST (PBSzero with 0.1% Tween 20). ORO stained 
embryos were transferred to 3% methylcellulose in order 
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to image them using a Zeiss Stemi SV11 microscope and 
a Nikon DXM1200 Digital Camera. The images were 
acquired using the Nikon ACT software (vs 2.63).
Measuring area of lipid staining
In the original files, four or five 5-dpf larvae were 
included per image. In order to avoid any measurement 
error, we made individual images by extracting the single 
larvae using Adobe Photoshop, without any further image 
manipulation. For each chemical exposure (DMSO, TBT, 
Ezh2i 50%epiboly and Ezh2i 5 dpf ), we measured Oil Red 
O staining in the abdominal region of larvae using Image 
J software (https ://image j.nih.gov/ij/) with the following 
settings (Image > Adjust > Color Threshold) Hue = 0; Satu-
ration levels set at values between Brightness depending 
on the histogram shown per image, followed by Thresh-
old color (Red) and Color Space (HSB). Then the images 
were filtered by red pixels and measured for the numbers 
of pixels containing a certain threshold for the red color. 
(Analyze > Measure). Per exposure we calculated the 
average area stained by Oil Red O.
Assay for transposase‑accessible chromatin
The chorion was removed with pronase (0.3 mg/mL pro-
nase) and the yolk was dissociated in 500 μL Ginzburg 
fish Ringer deyolk buffer (55  mM NaCl, 1.8  mM KCl, 
1.25 mM  NaHCO3) and the cell membrane was lysed in 
50 μL lysis buffer (10 mM Tris–HCl pH 7.4, 10 mM NaCl, 
3 mM  MgCl2, 0.1% Igepal CA630). A 2X DNA tagmenta-
tion buffer (22 mM Tris–HCl pH 7.4, 10 mM  MgCl2, 20% 
Dimethylformamide; pH 7.4) was prepared. The isolated 
nuclei were resuspended in 50  μL transposition reac-
tion mixture (25  μL 2X DNA tagmentation buffer, 1.25 
μL Tn5 (Illumina, 15027865), 23.75  μL  H2O). The sam-
ples were incubated on Thermomixer at 300 rpm, 37  °C 
for 30  min. The tagmented DNA was purified with the 
MinElute PCR Purification Kit (QIAGEN, cat. #28004) 
and eluted in 10 μL elution buffer. The Nextera Index Kit 
(Illumina, FC-121-1030) was used for the library prepa-
ration. Real-time PCR was performed using 1 μL of the 
transposed DNA and 9 μL qPCR master mix (1X NEB 
Next High-Fidelity PCR Master Mix (New England Labs, 
cat. #M0541), 1X SybrGreen, 0.25 nM indexed primers) 
to determine the number of PCR cycles needed for the 
library preparation. The temperature regime for the ther-
mocycling was (1) 72 °C for 5 min, (2) 98 °C for 30 s, (3) 
98 °C for 10 s, (4) 63 °C for 30 s, and (5) 72 °C for 30 s. 
Step 3–5 was repeated 20 times. The preferred number 
of amplification cycles for the libraries was decided to be 
9–10 cycles. The remaining 9  μL of purified transposed 
DNA was PCR amplified with 41 μL PCR master mix (1X 
NEB Next High-Fidelity PCR Mastermix (New England 
Labs, cat #M0541), 5  μM common and specific index 
primers (Nextera Index Kit, Illumina). The temperature 
regime for the thermocycling was (1) 72 °C for 5 min, (2) 
98 °C for 30 s, (3) 98 °C for 10 s, (4) 63 °C for 30 s, and (5) 
72  °C for 60  s. The amplified library was purified using 
the MinElute PCR Purification Kit and eluted in 20  μL 
of elution buffer. The libraries were cleaned up on a 2% 
agarose gel (Xe dry gel system, Invitrogen). During blue 
light excitation, the < 100  bp and > 15  kb localizations 
were removed, and the DNA libraries of interest were 
extruded from the gel using Invitrogen PureLink Quick 
Gel Extraction Kit (Invitrogen, cat. #K2100). The libraries 
were pair-end sequenced with a read length of 150 bases 
and a read depth of 50 million raw reads. The sequencing 
was outsourced to Novogene, Hong Kong, China.
Raw data processing and statistical analysis
Raw data files were mapped to GRCz11 using the bioin-
formatics pipeline snakePipes using the ATAC seq mode 
[48]. In this pipeline, fastq files are quality and adapter 
trimmed with Trim galore!, aligned with Bowtie2 and 
peaks are detected with MACS2. Due to too low read 
depths we needed to adjust the analysis by including 1 
nucleosome by increasing the fragment length to 300 bp. 
The obtained MACS peaks from each replicate were 
merged, and overlapping peaks were merged to one peak, 
resulting in 65336 peaks. The genomic locations were 
imported in Seqmonk v.1.45.4 and analyzed using EdgeR 
on raw read counts, setting the FDR at 0.05.
For Fig.  3e, published data sets were used to associ-
ate the observed ATAC peaks to different histone post-
translational modification and another ATAC dataset in 
zebrafish, namely ATAC-seq (PRJCA000283) [34], his-
tone H3 lysine 4 trimethylation (H3K4me3), H3K4me1, 
H3K27ac (GSE:32483) [35], H3K27me3 and H3K36me3 
(GSE44269) [36] data from dome stage (4.3 hpf ). After 
adapter and quality trimming with Trim galore! (v 0.4.1, 
Babraham Institute, UK), Bowtie2 (v2.2.9) was used for 
mapping. Bam files were loaded in Seqmonk (v1.45.4) 
and log2 normalized read counts were measured 10  kb 
up and downstream of ATAC peaks.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was done 
as described in Lindeman et  al. [49]. Antibodies, 
H3K4me3 (cat #. C15410003), H3K27me3 (cat # 
C15410069) and H3-pan (cat# C15310135) were pur-
chased from Diagenode, Belgium. ChIP-primers for 
cebpa locus were designed in Primer3 v4.0.0 [50, 51] 
and purchased from ThermoFisher Scientific (Addi-
tional file 1: Table S1). The precipitated DNA was quan-
tified with qPCR (SYBR green, Roche) using 2.5  µL 
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ChIP DNA as input template. Both ChIP and the qPCR 
experiments were performed in duplicates.
DATA analysis
Genes associated with significant ATAC peaks at their 
TSSs(349 genes) were used for gene ontology (GO) 
analysis (Gene Set Enrichment Analysis, gene ontology 
for biological processes) using the WebGestalt (WEB-
based GEne SeT AnaLysis Toolkit) online tool [52, 53]. 
The complete list of ATAC peaks located at TSSs was 
used as background for the overrepresentation analysis.
As a second dataset we selected all DEGs from 3.3 
hpf MZEzh2 mutant vs wild-type embryos [37] with an 
adjusted p-value < 0.05 (2904 genes). Using a Venn plot 
diagram (http://bioin forma tics.psb.ugent .be/webto ols/
Venn/) we compared this dataset with the gene list after 
ATAC-seq and the overlapping genes were subjected to 
GO term analysis as well.
RNA extraction and cDNA synthesis
Per experimental group (DMSO 0.01%; 1  nM TBT, 
short and long exposure to 5  µM Ezh2i), we had four 
replicates using 50 pooled embryos at 50% epiboly 
and 10 embryos at 5  dpf. Samples were taken from 
two independent exposure experiments, and snapfro-
zen and kept at − 80  °C Tissue homogenization was 
achieved using the Qiagen Tissue homogenizer: 2 × 30 s 
at 6000 rpm, and RNA extraction was performed using 
the NucleoSpin RNA Plus purification kit (Macherey-
Nagel GmbH & Co. KG, Düren, Germany, Cat. No. 
740984.50). After RNA extraction, an extra DNase I 
treatment was performed to remove genomic DNA. Per 
sample we added 4  µL 10× buffer; 1U/sample DNaseI 
RNase free (Roche, 4716728001). The tubes were incu-
bated for 15  min at 37  °C after which we added 1/10 
vol 3 M NaAc, 2 vol of ice-cold 100% ethanol (Merck, 
purity > 99.2%), 1  µL of GlycoBlue (Ambion, AM9516) 
and precipitated overnight at − 20  °C. The tubes were 
centrifuged at 13.000 rpm for 30 min, and the precipi-
tate was washed with 70% ethanol. Tubes were cen-
trifuged for 15  min at 13.000  rpm. Supernatant was 
removed, and pellet was air-dried for 10 min. RNA was 
dissolved in 30 µL UltraPure DEPC water (Invitrogen, 
750024)
Total RNA concentration was measured using a Nan-
oDrop 2000 (ThermoFisher) spectrophotometer. One µg 
of RNA was used for first-strand cDNA synthesis using 
the High-Capacity cDNA synthesis kit (Thermo Fischer, 
Applied Biosystems™, Foster City, California, USA, Cat. 
No. 4368814), and contained 8 mM dNTPs, random hex-
amers, 5 U/µL reverse transcriptase and 1.0 µg total RNA 
in a final volume of 20  µL. Reaction conditions were: 
10 min 25 °C, 120 min 37 °C and 5 min 85 °C. After syn-
thesis, 180 µL of DEPC treated water is added to a final 
volume of 200 µL (Invitrogen, Part no: 46-2224).
Gene expression analysis
We have selected genes that are known to have a role in 
the adipose tissue–gut–brain pathway and lipid metabo-
lism and four reference genes (hmbs, gapdh, hprt1, nono) 
were added to normalize our datasets. Next to that, we 
performed qPCR analysis for genes that did show a 
changed chromatin structure after ATAC-seq. Primers 
were developed using the primer blast tool from NCBI 
(https ://www.ncbi.nlm.nih.gov/tools /prime r-blast /), with 
an amplicon length between 70 and 200 bp, and anneal-
ing temperatures of 60 degrees, intron spanning, prefer-
ably one primer overlapping an exon–exon junction. For 
every primer set the efficiency was determined using 
serial dilutions of cDNA, and checked by gel electro-
phoresis. Table with primer sequences for target genes is 
available in Additional file 1: Table S3. QPCRs reactions 
were performed as described in den Broeder et al. [23].
Statistical analysis
Principal component analysis was performed using the 
online ClustVis tool (https ://biit.cs.ut.ee/clust vis/) [54]. 
As input we have used the individual replicated qPCR 
expression values per sample per exposure condition.
Change in lipid accumulation in 5-dpf-old larvae was 
analyzed by one way ANOVA analysis using Graphpad 
Prism 8.
The Cq determination was done by regression and 
extracted from BioRad CFX Maestro software. Normal-
ized Δ∆Cq levels were calculated, and significance anal-
ysis was performed on the log2 transformed values that 
were obtained via two-way ANOVA analysis with a Dun-
nett’s multiple comparison post hoc analysis in Graph-
Pad Prism 8. Results are presented in a heatmap at 5 dpf 
(GraphPad Prism 8) using the fold change expression 
values.
ChIP results were analyzed by two-way ANOVA with 
Sidak multiple comparisons correction using Graphpad 
Prism 8.
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1307 2-020-0329-y.
Additional file 1: Figure S1. Phred scores after sequencing analysis. 
Figure S2. Mapping analysis of data after alignment to the genome. 
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ID and sequences used for qPCR. 
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Additional file 2. A Microsoft Excel spreadsheet that contains Gene 
Ontology terms for Tab 1. Biological function Tab 2. cellular function, and 
Tab 3. molecular function.
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